| Value | ₹19.54 Cr |
|---|
NSE filing, NSE: HARDWYN. Summary written from the filing by ALFA Finder's alert engine.
Hardwyn India Ltd: key numbers
- Share price
- ₹8.92
- Market cap
- ₹610.0 Cr
- Revenue (annual)
- ₹199.9 Cr
- Net profit (annual)
- ₹13.21 Cr
- P/E (TTM)
- 46.2×Sector 40.5×
- Promoter holding
- 43.77%+0.00% QoQ
- FII holding
- 0.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hardwyn India Ltd
All →Hardwyn India Other Announcement
Hardwyn India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, per SEBI (LODR) Regulations. This is a routine compliance disclosure.
Hardwyn India Other Announcement
Hardwyn India Limited received a three-month extension from the ROC to hold its Annual General Meeting for the financial year ended March 31, 2026.
Hardwyn India Legal & Regulatory
Hardwyn India's board noted a ₹0.0325 Cr exchange fine for LODR board-composition non-compliance. The company has rectified the lapse and is seeking a waiver.
- Value
- ₹0.03 Cr
Hardwyn India Other Announcement
Hardwyn India Limited received an extension of three months from the Registrar of Companies to conduct its Annual General Meeting for the financial year 2025-26.
Hardwyn India Management Change
Hardwyn India Limited appointed Mr. Eakam Sayal as an Additional, Non-executive, and Non-Independent Director, effective August 29, 2026.
Hardwyn India Q1 FY27 Results: Net Profit ₹2.8 Cr, Down 22.2% YoY
Hardwyn India Ltd reported revenue from operations of ₹34.6 Cr (-19.3% YoY) and net profit of ₹2.8 Cr (-22.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2.8 Cr · -22.2% YoY
Other bonus issue announcements
All →Shivalik Bimetal Controls Bonus Issue
Shivalik Bimetal added a bonus share proposal and interim dividend to its 04 November 2026 board agenda. Trading window remains closed until 06 November 2026.
Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.